Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
OCUL
#1782
Ocular Therapeutix, Inc.
8.940
0
-3.14%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-3.14%
Changement Mensuel
-17.45%
Evolution sur 6 mois
-22.26%
Changement Annuel
-22.26%
Clôture Précédente
9.230
0
Open
8.940
0
Bid
Ask
Low
8.940
0
High
8.940
0
Volume
212
Marchés
Actions des Marchés US
Soins de Santé
OCUL
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
157.22 M
159.02 M
159.3 M
174 M
213.05 M
217.69 M
—
Valuation ratios
Enterprise value
940.57 M
965.95 M
817.99 M
1.22 B
2.15 B
1.91 B
6.09 B
Price to earnings ratio
-7.98
-7
-6.6
-7.48
-8.35
-8.55
-30.99
Price to sales ratio
17.58
21.21
19.24
26.57
35.13
43.75
124.69
Price to cash flow ratio
-9.44
-10.04
-8.01
-8.66
-10.39
-11.09
-38.15
Price to book ratio
0.97
4.29
0.88
1.22
1.71
3.47
7.28
Enterprise value to EBITDA ratio
29.65
34.18
-12.88
-20.42
-16.49
-125.77
-175.56
Profitability ratios
Return on assets %
0.07
0.11
0.16
0.15
0.17
0.08
0.56
Return on equity %
0.1
0.15
0.24
0.22
0.27
0.1
0.83
Return on invested capital %
—
—
—
—
—
-557.3
—
Gross margin %
89.88
92.8
88.2
85.56
87.8
87.97
349.53
Operating margin %
298.2
296.06
597.47
502.57
472.35
526.5
2 098.88
EBITDA margin %
16.78
12.9
-588.3
-13.2
-465
-517.09
-1 583.58
Net margin %
236.58
283.25
598.74
503.86
477.3
487.95
2 067.85
Liquidity ratios
Quick ratio
12.94
10.59
10.14
10.02
7.78
15.32
43.26
Current ratio
13.01
10.66
10.22
10.09
7.85
15.39
43.56
Inventory turnover
0.63
0.45
0.4
0.62
0.54
0.45
2.01
Asset turnover
0.03
0.04
0.02
0.03
0.03
0.02
0.11
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.14
0.15
0.17
0.15
0.17
0.09
0.59
Long term debt to total equity ratio
0.19
0.22
0.26
0.23
0.27
0.11
0.87
Per share metrics
Operating cash flow per share
0.22
0.25
0.26
0.32
0.28
0.29
1.15
EBIT per share
0.01
0.01
-0.38
-0.02
-0.37
-0.37
-1.14
EBITDA per share
0.02
0.01
-0.37
-0.01
-0.37
-0.37
-1.12
Total debt per share
—
—
—
—
—
—
—
Cash per share
2.56
2.48
2.06
2.27
1.87
3.94
10.14
Net current asset value per share
2.83
2.79
2.29
2.51
2.1
4.18
11.08
Tangible book value per share
2.11
1.99
1.57
1.77
1.4
3.49
8.24
Working capital per share
2.61
2.53
2.06
2.26
1.84
3.91
10.07
Book value per share
2.11
1.99
1.57
1.77
1.4
3.49
8.24
Nouvelles
Ocular Therapeutix首席开发官Kaiser出售2.3万美元股票
Ocular Therapeutix首席科学官Heier出售2.5万美元股票
Ocular Therapeutix CSO Heier sells $25k in stock
Ocular Therapeutix chief development officer Kaiser sells $23k in stock
Ocular Therapeutix首席执行官出售16.6万美元股票
Ocular Therapeutix CEO Dugel sells $166k in stock
Ocular Therapeutix首席医疗官Nadia Waheed出售2.7万美元股票
Waheed Nadia, Ocular Therapeutix CMO, sells $27k in stock
Needham因试验结果下调Ocular Therapeutix目标价
Ocular Therapeutix首席战略官Nayak出售9.3万美元股票
Ocular Therapeutix首席运营官Notman出售价值103,471美元的股票
Ocular Therapeutix首席医疗官Waheed出售7.1万美元股票